Asian Oncol Nurs.  2015 Mar;15(1):37-42. 10.5388/aon.2015.15.1.37.

Association of Depression and Survival in Patients with Cancer over 10 Years

• Kim J
• Lee SJ
• Roh JK
• Shin SJ

• KMID: 2269432
• DOI: http://doi.org/10.5388/aon.2015.15.1.37

Abstract

PURPOSE
This study was conducted to identify the effects of depression on the survival of patients with cancer over a 10 year period.
METHODS
A retrospective review was conducted to examine survival of 218 patients with stomach, colorectal and breast cancer, who had been treated for cancer from 2002 to 2011. Depression was assessed by using the Symptom Check List-90 Revision in 2002, and hope, fighting spirit and other potential confounders were also measured to control for their effects on the association between depression and the survival time. Data on survival were collected from the Statistics Korea and also from medical record in 2011. Kaplan-Meier survival analysis and Cox proportional hazard regression model were used to examine if depression affected survival.
RESULTS
The total number of death was 106, and the non-survivors scored higher on depression than survivors. Depression was found to be one of the influencing factors on survival from cancer.
CONCLUSION
Depression was significantly associated with the increased risk of death in cancer patients. Further research is needed to identify in details which type of emotional interventions can extend the survival time of cancer patients in depression.

Keyword

Neoplasms; Hope; Psychological Adjustment; Survival; Depression

MeSH Terms

Emotional Adjustment
Breast Neoplasms
Depression*
Hope
Humans
Korea
Medical Records
Retrospective Studies
Stomach
Survivors

Figure

• 

  Fig. 1 Kaplan-Meier Pots of Survival in Patients with Cancer by Severity of Depression

Reference

1. Statistics Korea. Mortality trends leading cause of death. Accessed March 27, 2015. Available from: http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=2770.

2. Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006; 28:396–402.

3. Hsiao FH, Kuo WH, Jow GM, Chang KJ, Yang PS, Lam HB, et al. Habitual sleep-wake behaviors and lifestyle as predictors of diurnal cortisol patterns in young breast cancer survivors: a longitudinal study. Psychoneuroendocrinology. 2015; 53:60–68.

4. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and in cancer patients. A meta-analysis. Cancer. 2009; 115:5349–5361.

5. Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer a secondary analysis. J Clin Oncol. 2011; 29:413–420.

6. Lee EK, Ryu EJ, Kim KH. Structual equaltion modeling on adjustment of cancer patients receiving chemotherapy. J Korean Oncol Nurs. 2011; 11(2):101–107.

7. Spiegel D, Giese-Davis J. Depression and cancer: mechanism and disease progression. Biol Psychiatry. 2003; 54:269–282.

8. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004; 32:57–71.

9. Kissane DW, Grabsch B, Love A, Clarke DM, Bloch S, Smith GC. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry. 2004; 38(5):320–326.

10. Lutgendorf SK, Lamkin DM, DeGeest K, Anderson B, Dao M, McGinn S, et al. Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer atients. Brain Behav Immun. 2008; 22:890–900.

11. Thornton LM, Andersen BL, Schuler TA, Carson WE 3rd. A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: Secondary analysis of a randomized controlled trial. Psychosom Med. 2009; 71:715–724.

12. Barrera I, Spiegel D. Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression. Int Rev Psychiatry. 2014; 26(1):31–43.

13. Jung KW, Won YJ, Kong HJ, Oh MC, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014; 46(2):109–123.

14. Kulpa M, Kosowicz M, Stypula-Ciuba BJ, Kazalska D. Anxiety and depression, cognitive coping strategies, and health locus of control in patients with digestive system cancer. Prz Gastroenterol. 2014; 9(6):329–335.

15. Johansson M, Ryden A, Finizia C. Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer - a longitudinal study. BMC Cancer. 2011; 11:283.

16. Kim J, Roh JK, Yoon JS, Lee SJ, Lee DY. Associations between depression, anxiety, hostility and fighting spirit among cancer patients in a cancer center in Korea. Cancer Res Treat. 2003; 35:411–418.

17. Kim J, Lee SJ, Lee WH. The relationship between spirituality and fighting spirit among cancer patients in Korea. J Korean Acad Adult Nurs. 2005; 17:583–591.

18. Lee SJ, Kim J, Park YM. Influence of depression on cancer metastasis. J Korean Oncol Nurs. 2008; 8(2):105–110.

19. Felder BE. Hope and coping in patients with cancer diagnoses. Cancer Nurs. 2004; 27:320–324.

20. Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jørgensen T. Depression as a prognostic factor for breast cancer mortality. Psychosomatics. 2003; 44(1):24–30.

21. Mols F, Husson O, Roukema JA, van de Poll-Franse LV. Depressive symptoms are a risk factor for all cause mortality: results from a prospective population-based study among 3080 cancer survivors from PROFILES registry. J Cancer Surviv. 2013; 7:484–492.

22. Miaskowski C, Cooper BA, Paul SM, Dodd M, Lee K, Aouizerat BE, et al. A.subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum. 2006; 33(5):E79–E89.

23. Sephton SE, Dhabhar FS, Keuroghlian AS, Giese-Davis J, McEwen BS, Ionan AC, et al. Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer. Brain Behav Immun. 2009; 23(8):1148–1155.

24. Thornton LM, Andersen BL, Schuler TA, Carson WE 3rd. A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial. Psychosom Med. 2009; 71:715–724.

25. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: A meta-analysis. Med Care. 2007; 45:521–528.

26. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007; 45:521–528.

27. Epstein RM, Street RL. Patient-centered communication in cancer care: promoting healing and reducing suffering. NIH Publication No.07-6225. Bethesda, MD: National Cancer Institute;2007.

28. Tae YS, Heitkemper M, Kim MY. A path analysis: a model of depression in Korean women with breast cancer-mediating effects of self-esteem and hope. Oncol Nurs Forum. 2012; 39(1):E49–E57.

29. Coyne JC, Tennen H. Positive psychology in cancer care: bad science, exaggerated claims, and unproven medicine. Ann Behav Med. 2010; 39:16–26.